Examining neurochemical determinants of inspection time: Development of a biological model

Intelligence

Volumn 29, Issue 6, 2001, Pages 511-522

  Stough, Con ^a   Thompson, J C ^a   Bates, T C ^b   Nathan, P J ^a  

^a SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^b MACQUARIE UNIVERSITY   (Australia)

Author keywords

Acetylcholine; Inspection time; Intelligence; Pharmacology

Indexed keywords

ACETYLCHOLINE; ALPHA ADRENERGIC RECEPTOR; CHOLINERGIC RECEPTOR; DOPAMINE RECEPTOR; NEUROTRANSMITTER; SEROTONIN RECEPTOR;

ACETYLCHOLINE RELEASE; ALZHEIMER DISEASE; ARTICLE; BIOLOGICAL MODEL; CENTRAL NERVOUS SYSTEM; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; HUMAN; INTELLIGENCE; INTELLIGENCE QUOTIENT; MENTAL PERFORMANCE; MENTAL TEST; NEUROCHEMISTRY; NORADRENERGIC SYSTEM; PSYCHOMETRY; SEROTONINERGIC SYSTEM; TASK PERFORMANCE;

EID: 0035555641     PISSN: 01602896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0160-2896(01)00077-0     Document Type: Article

References (66)

1. Anderson M. New ideas in intelligence. Psychologist: Bulletin of the British Psychological Society. 2(3):1989;92-94.
2. Arnsten A.F., Goldman-Rakic P.S. Catecholamines and cognitive decline in aged nonhuman primates. Annals of the New York Academy of Sciences. 444:1985;218-234.
3. Bates T., Mangan G., Stough C., Corballis P. Smoking, processing speed and attention in a choice reaction time task. Psychopharmacology. 120:1995;209-212.
4. Bates T.C., Pellett O., Stough C., Mangan G.L. The effects of smoking on simple and choice reaction time. Psychopharmacology. 106:1994;365-368.
5. Clark C.R., Geffen G.M., Geffen L.B. Catecholamines and the covert orientation of attention in humans. Neuropsychologia. 27:1989;131-139.
6. Comings D., Wu S., Chiu C., Ring R., Gade R., Ahn C., MacMurray J., Dietz G., Muhleman D. Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes-DRD2, D beta H, and DAT1. American Journal of Medical Genetics. 67:1996;264-288.
7. Coull J.T. Neural correlates of attention and arousal: insights from electrophysiology, functional neuroimaging and psychopharmacology. Progress in Neurobiology. 55:1998;343-361.
8. Deary I.J., Caryl P.G. Neuroscience and human intelligence differences. Trends in Neurosciences. 20(8):1997;365-371.
9. Deary I.J., Hunter R., Langan S.J., Goodwin G.M. Inspection time, psychometric intelligence and clinical estimates of cognitive ability in pre-senile Alzheimer's disease and Korsakoff's patients. Brain. 114:1991;2543-2554.
10. Deary I.J., Simonotto E., Marshall A., Goddard N., Wardlaw J.M. The functional anatomy of inspection time: a pilot fMRI study. Intelligence. 29:2001;497-510.
11. Deary I.J., Stough C. Intelligence and inspection time: achievements, prospects, and problems. American Psychologist. 51:1996;599-608.
12. Deary I.J., Stough C. Looking down on intelligence. American Psychologist. 52:1997;551-552.
13. Gaspar P., Berger B., Febvret A., Vigny A., Henry J. Catecholamine innervation of the human cerebral cortex as revealed by comparative immunohistochemistry of tyrosine hydroxylase and dopamine beta hydroxylase. Journal of Comparative Neurology. 279:1989;249-271.
14. Gill T.M., Sarter M., Givens B. Sustained visual attention performance-associated prefrontal neuronal activity: evidence for cholinergic modulation. Journal of Neuroscience. 20(12):2000;4745-4757.
15. Hasbroucq T., Rihet P., Blin O., Possamai C. Serotonin and human information processing: fluvoxamine can improve reaction time performance. Neuroscience Letters. 299:1997;204-208.
16. Haut M.W., Kuwabara H.O., Leach S., Callahan T. Age-related changes in neural activation during working memory performance. Aging, Neuropsychology, and Cognition. 7(2):2000;119-129.
17. Hindmarch I. Measuring the effect of psychoactive drugs on higher brain function. Advances in Human Psychopharmacology. 2:1981;99-127.
18. Hindmarch I., Bhatti J.Z. Psychopharmacological effects of sertraline in normal, healthy volunteers. European Journal of Clinical Pharmacology. 35:1988;221-223.
19. Hindmarch I., Harrison C. The effects of paroxetine and other antidepressants in combination with alcohol in psychomotor activity related to car driving. Human Psychopharmacology. 3:1988;13-20.
20. Hutchison C.W., Nathan P.J., Mrazek L., Stough C. Cholinergic modulation of speed of early information processing: the effect of donepezil on inspection time. Psychopharmacology. 44:2001;440-442.
21. Kegeles L.S., Mann J.J. In vivo imaging of neurotransmitter systems using radiolabeled receptor ligands. Neuropsychopharmacology. 17(5):1997;293-307.
22. Kennedy R.S., Odenheimer R.C., Baltzley D.R., Dunlap W.P., Wood C.D. Differential effects of scopolamine and amphetamine on microcomputer-based performance tests. Aviation, Space and Environmental Medicine. 61:1990;615-621.
23. Kessels R.P.C., Postma A., Wijnalda E., de-Haan E.H.F. Frontal lobe involvement in spatial memory: evidence from PET, fMRI, and lesion studies. Neuropsychology Review. 10(2):2000;101-113.
24. Kimberg D.Y., D'Espisito M., Farah M.J. Effects of bromocriptine on human subjects depend on working memory capacity. NeuroReport. 8(16):1997;3581-3585.
25. Kopf S.R., Baratti C.M. Effects of posttraining administration of insulin on retention of a habituation response in mice: participation of a central cholinergic mechanism. Neurobiology of Learning and Memory. 71:1999;50-61.
26. Kranzler J.H., Jensen A.R. Inspection time and intelligence: a meta-analysis. Intelligence. 13:1989;329-347.
27. Lader M., Melhuish A., Frcka G., FredricsonOver K., Christensen V. The effects of citalopram in single and repeated doses and with alcohol on physiological and psychological measures in healthy subjects. European Journal of Clinical Pharmacology. 31:1986;183-190.
28. le Novere N., Zoli M., Lena C., Ferrari R., Picciotto M.R., Merlo-Pich E., Changeux J.P. Involvement of alpha6 nicotinic receptor subunit in nicotine-elicited locomotion, demonstrated by in vivo antisense oligonucleotide infusion. NeuroReport. 10(12):1999;2497-2501.
29. Lena C., Changeux J.P. Role of Ca2+ ions in nicotinic facilitation of GABA release in mouse thalamus. Journal of Neuroscience. 17(2):1997;576-585.
30. Listerud M., Brussaard A.B., Devay P., Colman D.R., Role L.W. Functional contribution of neuronal AChR subunits revealed by antisense oligonucleotides. Science. 254:1991;1518-1521.
31. Luciana M., Collins P.F., Depue R.A. Opposing roles for dopamine and serotonin in the modulation of human spatial working memory functions. Cerebral Cortex. 8:1998;218-226.
32. Mackie, D., Thompson, & Stough, C. (submitted for publication). Deficits in the speed of early information processing speed in dementia of the Alzheimer's type.
33. McCrimmon R.J., Deary I.J., Huntly B.J.P., MacLeod K.J., Frier B.M. Visual information processing during controlled hypoglycaemia in humans. Brain. 119:1996;1277-1287.
34. McGaughy J., Sarter M. Behavioral vigilance in rats: task validation and effects of age, amphetamine, and benzodiazepine receptor ligands. Psychopharmacology. 117(3):1995;340-357.
35. Nathan P.J., Siteram G., Stough C., Silberstein R.B., Sali A. Serotonin, noradrenaline and cognitive function: a preliminary investigation of the acute pharmacodynamic effects of a serotonin versus a serotonin and noradrenaline reuptake inhibitor. Behavioural Pharmacology. 11:2000;639-642.
36. Nathan P.J., Stough C., Siteram G. Serotonin and information processing: a pharmacodynamic study on the effects of citalopram on cognitive and psychomotor function. Human Psychopharmacology: Clinical and Experimental. 15:2000;306-307.
37. Nettelbeck T. Inspection time and intelligence. Vernon P.A. Speed of information processing and intelligence. 1987;295-346 Ablex, Norwood, NJ.
38. Nettelbeck T., Young R. Inspection time and intelligence in 6-year-old children. Personality and Individual Differences. 10:1989;605-614.
39. Nettelbeck T., Young R. Inspection time and intelligence in 7-year-old children. Personality and Individual Differences. 11:1990;1283-1289.
40. Ollat H. Dopaminergic insufficiency reflecting cerebral ageing: value of a dopaminergic agonist, piribedil. Journal of Neurology. 239(Suppl. 1):1992;S13-S16.
41. Parrot A., Deary I. Scopolamine, cognition and dementia. Journal of Psychopharmacology. 6:1992;541-542.
42. Phillips J.M., Brown V.J. Reaction time performance following unilateral striatal dopamine depletion and lesions of the subthalamic nucleus in the rat. European Journal of Neuroscience. 11(3):1999;1003-1010.
43. Pomerleau O.F., Pomerleau C.S. Nicotine replacement: a critical evaluation. 1992;Haworth Press, New York.
44. Previc F.H. Dopamine and the origins of human intelligence. Brain and Cognition. 41:1999;299-350.
45. Pyman, Nathan, Thompson, & Stough (submitted for publication). The effects of 2 and 4 mg nicotine gum on the speed of early information processing.
46. Robbins T.W. Homology in behavioural pharmacology: an approach to animal models of human cognition. Behavioural Pharmacology. 9(7):1998;509-519.
47. Sarter M., Bruno J.P. Abnormal regulation of corticopetal cholinergic neurons and impaired information processing in neuropsychiatric disorders. Trends in Neurosciences. 22(2):1999;67-74.
48. Sawaguchi T., Goldman-Rakic P. D1 dopamine receptors in prefrontal cortex: involvement in working memory. Science. 251:1997;947-950.
49. Sawaguchi T., Matsumura M., Kubota K. Effects of dopamine antagonists on neural activity related to a delayed response task in monkey's prefrontal cortex. Journal of Neurophysiology. 63(6):1990;1401-1412.
50. 2-adrenergic antagonist idazoxan on mood, memory and attention in normal volunteers. Psychopharmacology. 6:1992;376-381.
51. Stahl S.M. Essential psychopharmacology. 2nd ed. 2000;Cambridge Univ. Press, London.
52. Stitzel J.A., Lu Y., Jimenez M., Tritto T., Collins A.C. Genetic and pharmacological strategies identify a behavioral function of neuronal nicotinic receptors. Behaviour Brain Research. 113(1-2):2000;57-64.
53. Stough C., Bates T., Mangan G.L., Pellett O. Smoking, string length and intelligence. Personality and Individual Differences. 18:1995;75-79.
54. Stough C., Brebner J., Nettelbeck T., Cooper C.J., Bates T.C., Mangan G.L. The relationship between intelligence, personality and inspection time. British Journal of Psychology. 87:1996;255-268.
55. Stough C., Mangan G., Bates T., Frank N., Kerkin B., Pellett O. Effects of nicotine on perceptual speed? Psychopharmacology. 107:1995;305-310.
56. Stough C., Mangan G.L., Bates T., Pellett O. Smoking and Raven IQ. Psychopharmacology. 106:1994;382-384.
57. Stough, C., Sitaram, G., & Nathan, P. (submitted). Examining the serotonin and noradrenalin neurotransmitter hypothesis for inspection time.
58. Stough, C., Singh, M., Lloyd, J., & Nathan, P.J. (submitted). Examining the effect of dopamine agonist on human intelligence.
59. Stough, C., Wilby, G., & Thompson, J. C. (submitted for publication). Transdermal nicotine administration and speed of information processing.
60. Tani Y., Saito K., Imoto M., Ohno T. Pharmacological characterization of nicotinic receptor-mediated acetylcholine release in rat brain - an in vivo microdialysis study. European Journal of Pharmacology. 351(2):1998;181-188.
61. Thompson J.C., Stough C., Nathan P.J., Ames D., Ritchie C. Effects of the nicotinic antagonist mecamylamine on inspection time. Psychopharmacology. 150(1):2000;117-119.
62. Vickers D., Nettelbeck T., Willson R.J. Perceptual indices of performance: the measurement of "inspection time" and "noise" in the visual system. Perception. 1:1972;263-295.
63. Volkow N., Gur R., Wang G., Fowler J. Association between decline in brain dopamine activity with age and cognitive and motor impairment in health individuals. American Journal of Psychiatry. 155(3):1998;344-348.
64. Warburton D.M. Nicotine as a cognitive enhancer. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 16:1992;181-191.
65. Waterham, I., Thompson, J. C., Nathan, P. J., & Stough, C. (submitted for publication).
66. Whitehouse P.J., Kalaria R.N. Nicotinic receptors and neurodegenerative dementing diseases: basic research and clinical implications. Alzheimer Disease and Associated Disorders. 2(Suppl. 9):1995;3-5.